Discover
DTIL
Precision BioSciences, Inc.
7.88
2 x 5.68
2 x 9.71
bid
ask
+
0.02
0.25%
2 @ 05:57 AM
7.85 -0.03 (0.38%)
| Ytd | 89.42% | |
| 1y | 90.80% |
7.57
day range
8.10
3.53
52 week range
8.82
| Open | 7.96 | Prev Close | 7.86 | Low | 7.57 | High | 8.10 | Mkt Cap | 203.32M |
| Vol | 445.29K | Avg Vol | 349.21K | EPS | -2.17 | P/E | N/A | Forward P/E | -0.66 |
| Beta | 1.69 | Short Ratio | 2.42 | Inst. Own | 44.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 7.12 | 200-d Avg | 5.74 | 1yr Est | 33.60 |
| Income Statement | |||
| Total Revenue | 10.84M | ||
| Revenues (USD) | 10.84M | ||
| Gross Profit | 10.84M | ||
| Operating Expenses | 19.91M | ||
| Research and Development Expense | 13.11M | ||
| Selling, General and Administrative Expense | 6.80M | ||
| Operating Income | -9.07M | ||
| Interest Expense | 311.00K | ||
| Net Income | -18.44M | ||
| Net Income Common Stock | -18.44M | ||
| Net Income Common Stock (USD) | -18.44M | ||
| Consolidated Income | -18.44M | ||
| Earnings per Basic Share | -0.75 | ||
| Earnings per Basic Share (USD) | -0.75 | ||
| Earnings per Diluted Share | -0.75 | ||
| Earning Before Interest & Taxes (EBIT) | -18.13M | ||
| Earning Before Interest & Taxes (USD) | -18.13M | ||
| Weighted Average Shares | 24.63M | ||
| Weighted Average Shares Diluted | 24.63M | ||
| Balance Sheet | |||
| Cash and Equivalents | 125.85M | ||
| Cash and Equivalents (USD) | 125.85M | ||
| Investments | 2.56M | ||
| Investments Current | 1.81M | ||
| Investments Non-Current | 744.00K | ||
| Trade and Non-Trade Receivables | 4.00M | ||
| Current Assets | 108.69M | ||
| Property, Plant & Equipment Net | 6.65M | ||
| Total Assets | 143.89M | ||
| Debt Current | 1.56M | ||
| Total Debt | 28.47M | ||
| Current Liabilities | 7.76M | ||
| Debt Non-Current | 26.91M | ||
| Total Liabilities | 67.79M | ||
| Accumulated Retained Earnings (Deficit) | -546.63M | ||
| Shareholders Equity | 76.10M | ||
| Shareholders Equity (USD) | 76.10M | ||
| Assets Non-Current | 35.20M | ||
| Total Debt (USD) | 28.47M | ||
| Deferred Revenue | 10.00M | ||
| Goodwill and Intangible Assets | 1.13M | ||
| Liabilities Non-Current | 60.04M | ||
| Trade and Non-Trade Payables | 944.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 640.00K | ||
| Net Cash Flow from Financing | 745.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.31M | ||
| Capital Expenditure | -14.00K | ||
| Issuance (Purchase) of Equity Shares | 745.00K | ||
| Net Cash Flow from Investing | -114.00K | ||
| Net Cash Flow from Operations | -11.94M | ||
| Share Based Compensation | 1.55M | ||